Julian DG, Valentine PA, Miller GG: Disturbances of rate, rhythm, and conduction in acute myocardial infarction . Am J Med37:915-927, 1964
2.
Lown B., Fakhro AM, Hood WB, et al: The coronary care unit. JAMA199:156-166, 1967
3.
Lown B., Wolf M.: Approaches to sudden death from coronary heart disease. Circulation44:130-142, 1971
4.
The Coronary Drug Project Research Group: Prognostic importance of premature beats following myocardial infarction . JAMA223:1116-1124, 1973
5.
Kotler MN, Tabatznik B., Mower MM, et al: Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation48:959-966, 1973
6.
Schulze RA, Strauss HW, Pitt B.: Sudden death in the year following myocardial infarction. Am J Med62:192-199, 1977
7.
Ruberman W., Weinblatt E., Goldberg JD, et al: Ventricular premature beats and mortality after myocardial infarction . N Engl J Med297:750-757, 1977
8.
Moss AJ, Davis HT, DeCamilla J., et al: Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation60:998-1003,1979
9.
Ruberman W., Weinblatt E., Goldberg JD, et al: Ventricular premature complexes and sudden death after myocardial infarction. Circulation64:297-305, 1981
10.
The Multicenter Postinfarction Research Group : Risk stratification after myocardial infarction. N Engl J Med309:331-336, 1983
11.
Bigger JT, Fleiss JL, Kleiger R., et al: The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation69:250-258, 1984
12.
Mukharji J. , Rude R., Poole WK, et al: Risk factors for sudden death after acute myocardial infarction: Two-year follow-up. Am J Cardiol54:31-36, 1984
13.
Chiang BN, Perlman LV, Ostrander LD, et al: Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study. Ann Intern Med70:1159-1166, 1969
14.
Hinkle LE, Carver ST, Stevens M.: The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol24:629-650, 1969
15.
Rodstein M. , Wolloch L., Gubner RS: Mortality study of the significance of extrasystoles in an insured population. Circulation44:617-625, 1971
16.
Desai DC, Hershberg PI, Alexander S.: Clinical significance of premature ventricular beats in an outpatient population . Chest64:564-569, 1973
17.
Hinkle LE, Carver ST, Argyros DC: The prognostic significance of ventricular premature contractions in healthy people and in people with coronary heart disease. Acta Cardiol18:5-32, 1974
18.
Lie KI, Wellens HJ, Durrer D.: Characteristics and predictability of primary ventricular fibrillation . Eur J Cardiol1:379-384, 1974
19.
EI-Sherif N. , Myerburg RJ, Scherlag BJ, et al: Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R-on-T phenomenon in myocardial infarction. Br Heart J38:415-422, 1976
20.
Brodsky M., Wu D., Denes P., et al: Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol39:390-395, 1977
21.
Kennedy HL, Whitlock JA, Sprague MK, et al: Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med312:193-197, 1985
22.
Blackburn H. , DeBacker G., Crow R., et al: Epidemiology and prevention of ventricular ectopic rhythms. Adv Cardiol18:208-216, 1976
23.
Kennedy HL, Underhill SJ: Frequent or complex ventricular ectopy in apparently healthy subjects. A clinical study of 25 cases. Am J Cardiol38:141-148, 1976
24.
Winkle RA: Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy. Circulation57:1116-1121, 1978
25.
Morganroth J., Michelson EL, Horowitz LN, et al: Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopy frequency. Circulation58:408-414, 1978
26.
Romhilt DW, Bloomfield SS, Chou T., et al: Unreliability of conventional electrocardiographic monitoring for arrhythmia detection in coronary care units. Am J Cardiol31:457-461, 1973
27.
Koch-Weser J., Klein SW, Foo-Canto LL, et al: Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. N Engl J Med281:1253-1260, 1969 28. Kosowsky BD, Taylor J., Lown B., et al: Long-term use of procaine amide following acute myocardial infarction . Circulation47:1204-1210, 1973
28.
Holmberg S. , Bergman H.: Prophylactic quinidine treatment in myocardial infarction. A double blind study. Acta Med Scand181:297-304,1967
29.
Anderssen N. , Erikssen J., Muller C.: The prophylactic antiarrhythmic effect of quinidine in myocardial infarction. Acta Med Scand184:171-176, 1968
30.
Bloomfield SS , Romhilt DW, Chou T., et al: Quinidine for prophylaxis of arrhythmias in acute myocardial infarction. N Engl J Med285:979-986, 1971
31.
Jones DT, Kostuk WJ, Gunton RW: Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarction. Am J Cardiol33:655-660, 1974
32.
The Collaborative Group: Phenytoin after recovery from myocardial infarction. Lancet2:1055-1057, 1971
33.
Peter T., Ross D., Duffield A., et al: Effect on survival after myocardial infarction of long-term treatment with phenytoin. Br Heart J40:1356-1360, 1978
34.
Jennings G. , Jones Mbs, Besterman Emm, et al: Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet1:51-54, 1976
35.
Lie KI, Wellens HJ, VanCapelle FJ, et al: Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med291:1324-1326, 1974
36.
Myerburg RJ , Zaman L., Kessler KM, et al: Evolving concepts of management of stable and potentially lethal arrhythmias. Am Heart J103:615-625, 1982
37.
Vlay SC: How the university cardiologist treats ventricular premature beats: A nationwide survey of 65 university medical centers. Am Heart J110:904-912, 1985
38.
The CAPS Investigators: The cardiac arrhythmia pilot study. Am J Cardiol57:91-95, 1986
39.
The Cardiac Arrhythmia Pilot Study Investigators : Effects of encainide, flecainide, imipramine, and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS. Am J Cardiol61:501-509, 1988
40.
The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med321:406-412, 1989
41.
Ruskin JN: The Cardiac Arrhythmia Suppression Trial. N Engl J Med321:386-388,1989 (edit)
42.
Pratt CM, Moye LA: The Cardiac Arrhythmia Suppression Trial: Background, interim results and implications. Am J Cardiol65:20B-29B, 1990 (suppl)
43.
Akhtar M., Breithardt G., Camm AJ, et al: CAST and beyond: Implications of the Cardiac Arrhythmia Suppression Trial. Circulation81:1123-1127, 1990
44.
Bauman JL: Results of the CAST ... What did we catch?Pharmacotherapy9:267-268, 1989
45.
Riker/3M Company: Personal communication. March, 1990
46.
McCollam PL , Parker RB, Beckman KJ, et al: Proarrhythmia: A paradoxic response to antiarrhythmic agents. Pharmacotherapy9:144-153, 1989
47.
Bauman JL, Bauernfeind RA, Hoff JV, et al: Torsade de pointes due to quinidine: Observations in 31 patients . Am Heart J107:425-430, 1984
48.
Kay GN, Plumb VJ, Arciniegas JG, et al: Torsade de pointes: The long-short initiating sequence and other clinical features: Observations in 32 patients. JACC2:806-817, 1983
49.
Keren A., Tzivoni D., Gavish D., et al: Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients. Circulation64:1167-1174, 1981
50.
Stratmann HG , Kennedy HL: Torsades de pointes associated with drugs and toxins: Recognition and management. Am Heart J113:1470-1482, 1987
51.
Winkle RA, Mason JW, Griffin JC, et al: Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J102:857-864, 1981
52.
Nathan A., Hellestrand K., Bexton R., et al: The proarrhythmic effects of the new antiarrhythmic drug flecainide acetate. J Am Coll Cardiol1:709, 1983 (abstr)
53.
Morganroth J., Horowitz LN: Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol53:89B-94B, 1984
54.
Berns E., Rinkenberger RL, Jeang MK, et al: Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. Am J Cardiol59:1337-1341, 1987
55.
Quattromani A., Smith P., Schechtman KB, et al: Efficacy of flecainide in the treatment of atrial tachyarrhythmias. J Am Coll Cardiol11:228, 1988 (abstr)
56.
Bauman JL, Berk SI, Hariman RJ, et al: Amiodarone for sustained ventricular tachycardia: Efficacy, safety, and factors influencing long-term outcome. Am Heart J114:1436-1444,1987
57.
Gallastegui JL, Bauman JL, Anderson JL, et al: Worsening of ventricular tachycardia by amiodarone. J Clin Pharmacol28:406-411, 1988
58.
Mattioni T. , Zheutlin TA, Sarmiento JJ, et al: Amiodarone in patients with previous drug-mediated torsade de pointes: Long term safety and efficacy. Ann Intern Med111:574-580, 1989
